LOGO - COLOR InvestorsInvestor Kit Investor Kit Information for Informed Investment Decisions Verastem Oncology, Inc. (NASDAQ: VSTM), is a biopharmaceutical company headquartered in Needham, MA. The focus of our research is developing a portfolio of novel small molecule drugs that inhibit critical RAS signaling pathways that promote cancer cell survival and tumor growth. To learn more about our research program, as well as the details of our financials, please download the investor kits below. Verastem Oncology is a member of NASDAQ Biotechnology Index. Corporate Presentation Well Positioned to Capitalize on Growth Opportunities DOWNLOAD Corporate Latest 10-K Annual Report for the Fiscal Year Ending December 31, 2020 DOWNLOAD Corporate Proxy Statement Proxy Statement for Annual Meeting of Stockholders Held May 18, 2021 DOWNLOAD Investor Contact Ajay Munshi Investor Relations (781) 469-1579 info@verastem.com Sherri Spear Argot Partners (617) 533-0020 sherri@argotpartners.com Investor FAQ View Stock Information Sign Up for Alerts Terms of Use Copyright Statement Privacy Policy Contact © 2021 Verastem, Inc. All Rights Reserved.